Get the Stockscreener App
14.71
0.41%
0.06
After Hours:
14.71
Tyra Biosciences Inc Stock (TYRA) Latest News
Tyra Biosciences appoints new board member - MSN
Tyra Biosciences Insider Ups Holding By 284% During Year - Simply Wall St
Tyra Biosciences adds Adele Gulfo to board By Investing.com - Investing.com South Africa
Tyra Biosciences adds Adele Gulfo to board - MSN
Tyra Biosciences appoints new board member By Investing.com - Investing.com Nigeria
Tyra Biosciences, Inc. Appoints Adele Gulfo to its Board of Directors -January 29, 2025 at 04:05 pm EST - Marketscreener.com
(TYRA) Trading Advice - Stock Traders Daily
Tyra Biosciences director Nina Kjellson sells $78,466 in stock - MSN
Insider Selling: Tyra Biosciences, Inc. (NASDAQ:TYRA) Director Sells 4,825 Shares of Stock - MarketBeat
Tyra Biosciences director Nina Kjellson sells $78,466 in stock By Investing.com - Investing.com Canada
Private equity firms account for 44% of Tyra Biosciences, Inc.'s (NASDAQ:TYRA) ownership, while institutions account for 33% - Yahoo Finance
Tyra Biosciences, Inc. (NASDAQ:TYRA) is Canaan Partners XI LLC's Largest Position - MarketBeat
Tyra Biosciences, Inc. (NASDAQ:TYRA) Director Sells $126,719.91 in Stock - MarketBeat
Nina S. Kjellson Sells 3,993 Shares of Tyra Biosciences, Inc. (NASDAQ:TYRA) Stock - MarketBeat
Tyra Biosciences Announces Poster Presentations at 2025 ASCO Gastrointestinal Cancers Symposium - Citizentribune
Tyra Biosciences to Present Two Cancer Drug Studies at 2025 ASCO GI Symposium - StockTitan
Tyra Biosciences director Nina Kjellson sells shares worth $409,645 By Investing.com - Investing.com Australia
Tyra Biosciences director Nina Kjellson sells shares worth $409,645 - MSN
Trading (TYRA) With Integrated Risk Controls - Stock Traders Daily
Tyra Biosciences (NASDAQ:TYRA) Stock Price Down 4.1%Time to Sell? - MarketBeat
Barclays PLC Has $884,000 Position in Tyra Biosciences, Inc. (NASDAQ:TYRA) - Defense World
Tyra Biosciences (NASDAQ:TYRA) Trading 7.9% HigherHere's What Happened - MarketBeat
JPMorgan Chase & Co. Has $8.67 Million Stock Holdings in Tyra Biosciences, Inc. (NASDAQ:TYRA) - Defense World
Tyra Biosciences (NASDAQ:TYRA) Given Buy Rating at HC Wainwright - Defense World
Tyra Biosciences' (TYRA) Buy Rating Reaffirmed at HC Wainwright - MarketBeat
FDA greenlights phase 2 SURF302 trial of TYRA-300 in NMIBC - Urology Times
Tyra Falls on FDA Nod - Baystreet.ca
Tyra Biosciences advances bladder cancer drug trial - Investing.com
Tyra Biosciences advances bladder cancer drug trial By Investing.com - Investing.com South Africa
Tyra Biosciences Secures FDA Clearance for TYRA-300 Phase 2 Bladder Cancer Trial - StockTitan
Tyra Biosciences, Inc. (NASDAQ:TYRA) Receives $31.00 Average Target Price from Brokerages - Defense World
UBS Group Initiates Coverage on Tyra Biosciences (NASDAQ:TYRA) - Defense World
Long Term Trading Analysis for (TYRA) - Stock Traders Daily
Tyra Biosciences, Inc. (NASDAQ:TYRA) Receives Consensus Recommendation of "Buy" from Analysts - MarketBeat
Tyra Biosciences (NASDAQ:TYRA) Coverage Initiated at UBS Group - MarketBeat
UBS backs Tyra Biosciences stock with long-term growth forecast driven by TYRA-300 pipeline - Investing.com Canada
12,647 Shares in Tyra Biosciences, Inc. (NASDAQ:TYRA) Bought by Franklin Resources Inc. - Defense World
Tyra Biosciences, Inc. (NASDAQ:TYRA) Stake Lifted by Barclays PLC - Defense World
Tyra Biosciences, Inc. (NASDAQ:TYRA) Sees Significant Growth in Short Interest - MarketBeat
(TYRA) Trading Report - Stock Traders Daily
State Street Corp Acquires 16,248 Shares of Tyra Biosciences, Inc. (NASDAQ:TYRA) - Defense World
Head to Head Contrast: Tyra Biosciences (NASDAQ:TYRA) and Checkpoint Therapeutics (NASDAQ:CKPT) - Defense World
Tyra Biosciences (NASDAQ:TYRA) Stock Price Down 4.3%What's Next? - MarketBeat
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Acquires New Position in Tyra Biosciences, Inc. (NASDAQ:TYRA) - Defense World
Wellington Management Group LLP Sells 26,207 Shares of Tyra Biosciences, Inc. (NASDAQ:TYRA) - Defense World
The Take On Tyra Biosciences (NASDAQ:TYRA) - Seeking Alpha
(TYRA) Trading Signals - Stock Traders Daily
Tyra Biosciences to Present at Upcoming Investor Conferences - The Eastern Progress Online
The Manufacturers Life Insurance Company Invests $333,000 in Tyra Biosciences, Inc. (NASDAQ:TYRA) - Defense World
Charles Schwab Investment Management Inc. Increases Stake in Tyra Biosciences, Inc. (NASDAQ:TYRA) - Defense World
We're Not Very Worried About Tyra Biosciences' (NASDAQ:TYRA) Cash Burn Rate - Simply Wall St
Frazier Life Sciences Management L.P. Cuts Stake in Tyra Biosciences, Inc. (NASDAQ:TYRA) - MarketBeat
Tyra Biosciences to Host Conference Call on Interim Clinical Data of TYRA-300 from SURF301 Phase 1/2 Study on October 25, 2024, at 8am ET - Victoria Advocate
5.49%
0.79%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):